Related Experiment Video
Updated: Jul 1, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Visualization Methods for Uterine Sentinel Lymph Nodes in Early-Stage Endometrial Carcinoma: A Comparative Analysis
Linas Andreika1, Karolina Vankevičienė2, Diana Ramašauskaitė1
1Clinic of Obstetrics and Gynecology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21/27, LT-03101 Vilnius, Lithuania.
Combining Indocyanine green (ICG) and methylene blue (MB) tracers significantly improves sentinel lymph node (SLN) detection rates in early-stage endometrial cancer compared to using MB alone.
Area of Science:
- Gynecology
- Surgical Oncology
- Oncologic Imaging
Background:
- Sentinel lymph node (SLN) biopsy is preferred for early-stage endometrial cancer over systematic lymphadenectomy due to lower morbidity.
- Accurate SLN identification is crucial for staging and treatment planning.
Purpose of the Study:
- To compare the overall and bilateral detection rates of SLN using Indocyanine green (ICG), methylene blue (MB), and a combination (ICG+MB).
Main Methods:
- A prospective cohort study involving 99 patients with early-stage endometrial cancer.
- Three tracer groups were evaluated: ICG, MB, and ICG+MB.
- Comparison of mapping characteristics, detection rates, and number of SLNs identified.
Main Results:
- The overall SLN detection rate was 54.3% for MB, 72.7% for ICG, and 80.6% for ICG+MB.
- Bilateral detection rates were 22.9% (MB), 39.4% (ICG), and 54.8% (ICG+MB).
- The MB group showed significantly inferior results compared to the other groups.
Conclusions:
- Combining ICG and MB tracers enhances SLN identification accuracy in early-stage endometrial cancer.
- The ICG+MB combination demonstrated superior overall and bilateral detection rates.
- This combined approach increases accuracy without additional patient risk.
More Related Videos
06:37Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019